Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03942484 · ClinicalTrials.gov registry record · NA
Efficacy of rPMS for Improvement of Urinary Incontinence and Female Sexual Function
A NA study of Urinary Incontinence, sponsored by BTL Industries.
- Completed
- Registry status
- NA
- Development phase
- 45
- Enrollment target
- 5
- Study locations
NCT03942484: Completed NA study of Urinary Incontinence, sponsored by BTL Industries.
NCT03942484 is a NA study of Urinary Incontinence that has completed, run by BTL Industries. The registered enrollment target is 45 participants, below the 261-participant average among 48 other Urinary Incontinence trials with a reported enrollment target (83% lower). The trial reports 5 study locations across 5 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03942484, a NA study of Urinary Incontinence, has completed, sponsored by BTL Industries.
- COMPLETED
- Registry status
- NA
- Development phase
- 45 participants
- Enrollment target
- 5
- Study locations
Study Summary
Evaluation of the repetitive pulse magnetic stimulation (rPMS) for the treatment of urinary incontinence and a female sexual satisfaction.
Primary Outcome
Evaluation of change in ICIQ-UI score. Decrease of the score will be considered as an improvement.
Conditions Studied
Interventions
- DEVICE rPMS device
Study Locations (5)
Kentucky
- Julene Samuels - Louisville
Michigan
- Joseph Berenholz - Farmington Hills
New Jersey
- Gynecological Solutions - Hillsborough
South Carolina
- Southern Urogynecology - West Columbia
Texas
- Hillcroft Medical Clinic - Sugar Land
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2019-05-01 |
| Est. Completion | 2021-10-20 |
| Phase | NA |
What the finished NCT03942484 record still lists
NCT03942484 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 45 participants, a relatively small participant target, below the 261-participant average among 48 other Urinary Incontinence trials with a reported enrollment target (83% lower).
The record links to 1 condition, with Urinary Incontinence appearing as the primary indexed condition, and to 1 intervention - of which rPMS device is the first listed.
NCT03942484 lists 5 locations in 5 states (Kentucky, Michigan, New Jersey).
Frequently Asked Questions
What is clinical trial NCT03942484 about?
NCT03942484 is a clinical study titled "Efficacy of rPMS for Improvement of Urinary Incontinence and Female Sexual Function". Evaluation of the repetitive pulse magnetic stimulation (rPMS) for the treatment of urinary incontinence and a female sexual satisfaction.
What is the current status of trial NCT03942484?
This trial is currently completed. It is a NA study. The enrollment target is 45 participants. The study started on 2019-05-01. Estimated completion is 2021-10-20.
What conditions does trial NCT03942484 study?
This clinical trial studies the following conditions: Urinary Incontinence.
What interventions are being tested in trial NCT03942484?
The interventions under investigation include: rPMS device (DEVICE).
Who is sponsoring clinical trial NCT03942484?
This trial is sponsored by BTL Industries, which has 40 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03942484 being conducted?
This trial has 5 study locations across Kentucky, Michigan, New Jersey, South Carolina, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Urinary Incontinence
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03942484's enrollment target sits among peer trials
45 34th of 48 higher than 15 of 48 other Urinary Incontinence trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Urinary Incontinence trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Trial of Transurethral Bulking Agent Injection Versus Single-Incision Sling for Stress Urinary Incontinence
RECRUITING · NA
-
TENS Analgesia During Outpatient Urethral Bulking for Stress Urinary Incontinence.
RECRUITING · NA
-
Adjustable Continence Therapy (ACT) for the Treatment of Female SUI
RECRUITING · NA
-
Improving Overactive Bladder Treatment Access and Adherence
RECRUITING · NA
-
Training for Urinary Leakage Improvement After Pregnancy
RECRUITING · NA
-
Home Biofeedback Therapy for Dyssynergic Defecation, Fecal Incontinence and Urinary Incontinence
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00804154 · 45 participants · Phase 1
Resiniferatoxin to Treat Severe Pain Associated With Advanced Cancer
- NCT01851694 · 45 participants · NA
Beta-cell Response to Incretin Hormones in Cystic Fibrosis
- NCT02896335 · 45 participants · Phase 2
Palbociclib and Pembrolizumab In Central Nervous System Metastases
- NCT03454035 · 45 participants · Phase 1
Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI